Dong-Kyun Ryu

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Ji-Min Seo, Bobin Kang, Rina Song, Hanmi Noh, Cheolmin Kim, Jong-In Kim, Minsoo Kim, Dong-Kyun Ryu, Min-Ho Lee, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee, Hansaem Lee, Hye-Min Woo, Jun-Won Kim, Jung-Ah Choi, Man Ki Song, Monika Tomaszewska-Kiecana, Anna Wołowik, Agnieszka Kulesza, Sung Hyun Kim, Keum Young Ahn, Nahyun Jung, Soo-Young Lee
Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging microbes & infections 11 (1) (2022)
Cheolmin Kim, Dong-Kyun Ryu, Jihun Lee, Young-Il Kim, Ji-Min Seo, Yeon-Gil Kim, Jae-Hee Jeong, Minsoo Kim, Jong-In Kim, Pankyeom Kim, Jin Soo Bae, Eun Yeong Shim, Min Seob Lee, Man Su Kim, Hanmi Noh, Geun-Soo Park, Jae Sang Park, Dain Son, Yongjin An, Jeong No Lee, Ki-Sung Kwon, Joo-Yeon Lee, Hansaem Lee, Jeong-Sun Yang, Kyung-Chang Kim, Sung Soon Kim, Hye-Min Woo, Jun-Won Kim, Man-Seong Park, Kwang-Min Yu, Se-Mi Kim, Eun-Ha Kim, Su-Jin Park, Seong Tae Jeong, Chi Ho Yu, Youngjo Song, Se Hun Gu, Hanseul Oh, Bon-Sang Koo, Jung Joo Hong, Choong-Min Ryu, Wan Beom Park, Myoung-Don Oh, David Hyunjung Chung, Soo-Young Lee
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein. Nature communications 12 (1) (2021)

Dong-Kyun Ryu.css-eqlu8i{font-size:small;padding-left:4px;}